Evidence map›Paper›PMID 39050787›Full record

ArticleReproductive medicine and biology

Risk factors for non-previa placenta accreta spectrum in pregnancies conceived through frozen embryo transfer during a hormone replacement cycle in Japan.

Seiko Matsuo, Tomomi Kotani, Sho Tano, Takafumi Ushida, Kenji Imai, Tomoko Nakamura, Satoko Osuka, Maki Goto, Masami Osawa, Yoshimasa Asada and 1 more

Abstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seiko MatsuoDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.
Tomomi KotaniDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.ORCID https://orcid.org/0000-0002-3082-6116
Sho TanoDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.
Takafumi UshidaDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.
Kenji ImaiDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.
Tomoko NakamuraDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.
Satoko OsukaDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.ORCID https://orcid.org/0000-0002-4430-7982
Maki GotoDepartment of Obstetrics and Gynecology Okazaki City Hospital Okazaki Japan.
Masami OsawaNarita Obstetrics and Gynecology Nagoya Japan.
Yoshimasa AsadaAsada Ladies Clinic Nagoya Japan.ORCID https://orcid.org/0000-0002-0448-9953
Hiroaki KajiyamaDepartment of Obstetrics and Gynecology Nagoya University Graduate School of Medicine Nagoya Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Non-previa placenta accreta spectrum (PAS) is associated with assisted reproductive technology (ART), particularly frozen embryo transfer during hormone replacement therapy (HRC-FET). We especially aimed to evaluate the prevalence and risk factors for non-previa PAS in HRC-FET pregnancies. Methods: Overall, 279 women who conceived through ART at three ART facilities and delivered at a single center were included in this retrospective study. Data regarding endometrial thickness at embryo transfer, previous histories, and type of embryo transfer-HRC-FET, frozen embryo transfer during a natural ovulatory cycle (NC-FET), and fresh embryo transfer (Fresh-ET)-were collected. Univariable logistic regression analyses were conducted. Results: The prevalence of non-previa PAS was 27/192 (14.1%) in the HRC-FET group and 0 (0.0%) in both the NC-FET and Fresh-ET groups. Significantly high odds ratio [95% confidence interval] of non-previa PAS was associated with a history of artificial abortion (6.45 [1.98-21.02]), endometrial thickness <8.0 mm (6.11 [1.06-35.12]), resolved low-lying placenta (5.73 [2.13-15.41]), multiparity (2.90 [1.26-6.69]), polycystic ovarian syndrome (2.62 [1.02-6.71]), and subchorionic hematoma (2.49 [1.03-6.04]). Conclusions: A history of artificial abortion, endometrial thickness <8.0 mm, and resolved low-lying placenta may help in antenatal detection of a high-risk population of non-previa PAS in HRC-FET pregnancies.

Indexed as

assisted reproductive technologyfrozen embryo transferhormone replacement cyclenon‐previa placenta accreta spectrumplacenta accreta spectrum

Identifiers

PMID39050787
PMCPMC11266119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.